MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia with Lewy bodies (DLB)"

  • MDS Virtual Congress 2021

    Palliative care evaluation for movement disorders during COVID-19: Using Tele neurology to provide real-time care for an at risk Veterans Population.

    N. Hack, K. Dalton (Rockville, USA)

    Objective: To deliver palliative care via telemedicine in a video format to veterans at risk with movement disorders in need of palliative care in the…
  • MDS Virtual Congress 2021

    Long-term cognitive and motor decline across the spectrum of Lewy body disease.

    MC. Gonzalez, J. Maple-Grødem, D. Tovar‐rios, CH. Williams-Gray, M. Camacho, L. Forsgren, D. Bäckström, R. Lawson, AD. Macleod, CE. Counsell, C. Paquet, C. Falup-Pecurariu, F. Blanc, A. Padovani, C. de Lena, F. D'Antonio, G. Alves, D. Aarsland (Stavanger, Norway)

    Objective: This study aims to compare the progression of motor and cognitive decline in dementia with Lewy bodies (DLB) compared with Parkinson’s disease (PD) using…
  • MDS Virtual Congress 2021

    Spatiotemporal dynamics in mild cognitive impairment with Lewy bodies

    M. Lamoš, I. Morávková, D. Ondráček, M. Bočková, I. Rektorová (Brno, Czech Republic)

    Objective: To explore whether EEG microstate evaluation may help in identifying mild cognitive impairment with Lewy bodies (MCI-LB) and to assess whether the changes correlate…
  • MDS Virtual Congress 2021

    Differentiating Gait Impairments in Early Parkinson’s Disease and Early Dementia with Lewy Bodies

    K. Mathias, A. Pinto, E. Matar, J. Phillips, S. Lewis, K. Ehgoetz Martens (Waterloo, Canada)

    Objective: To characterize and differentiate gait deficits early on in individuals with DLB and PD. Background: Dementia with Lewy bodies (DLB) and Parkinson’s disease (PD)…
  • MDS Virtual Congress 2021

    Effects of white matter hyperintensities, neuropsychiatric symptoms, and cognition on activities of daily living: Differences between Dementia with Lewy Bodies and Alzheimer’s disease

    S. Mirza, U. Saeed, J. Ramirez, N. Herrmann, S. Black, M. Masellis (Toronto, Canada)

    Objective: To investigate if White matter hyperintensities (WMHs), neuropsychiatric symptoms and cognitive performance associate with, and/or predict activities of daily living (ADLs) differently in Alzheimer’s…
  • MDS Virtual Congress 2021

    Prevalence of Suicidal Ideation and Associated Clinical Features in Lewy Body Dementia

    K. Moore, M. Armstrong, C. Jacobson, N. Gamez, B. Patel, J. Sullivan (Gainesville, USA)

    Objective: The goal of this study was to identify the prevalence of suicidal ideation (SI) in Lewy body dementia (LBD) and the factors associated with…
  • MDS Virtual Congress 2021

    Event-related oscillations in patients with Dementia with Lewy Bodies with and without mutations in the GBA gene

    Y. Rosenblum, N. Bregman, A. Thaler, A. Orr-Urtreger, N. Giladi, A. Mirelman, T. Shiner (Tel Aviv, Israel)

    Objective: To explore the differences in the structure of event-related oscillations (ERO) elicited by a visual oddball task in Dementia with Lewy bodies (DLB) patients…
  • MDS Virtual Congress 2021

    Elucidating multimodal endophenotypes of APOE-ε4 in α-synucleinopathies

    U. Saeed, SS. Mirza, SE. Black, M. Masellis (Toronto, Canada)

    Objective: To systematically identify phenotypes that consistently associate with the ε4-allele of apolipoprotein E (APOE-ε4) in α-synucleinopathies. Background: The APOE-ε4 presents an elevated risk not…
  • MDS Virtual Congress 2020

    Behavioral and Psychological Symptoms in Patients with Movement Disorders

    M. Kulsum, S. Anand, H. Kumar (Kolkata,, India)

    Objective: To find out the prevalence of neuropsychiatric symptoms in patients with Movement Disorders. To find out the relationship between cognitive impairment and neuropsychiatric symptoms…
  • MDS Virtual Congress 2020

    α-Synuclein propagation via olfactory pathway induces olfactory bulb atrophy and widespread glucose hypometabolism in a non-human primate model

    M. Sawamura, H. Onoe, H. Tsukada, K. Isa, N. Uemura, T. Isa, R. Takahashi (Kyoto, Japan)

    Objective: We investigated how α-synuclein (α-Syn) pathology spreads from the olfactory bulb (OB) and how the pathology affects brain structure and activity. Background: Parkinson's disease…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley